cp wire

CP Wire Articles

FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
  • Glucagon is the standard of care for treating severe hypoglycemia
  • Mild to moderate hypoglycemia occurs monthly and severe hypoglycemia can occur several times per year
  • The... read more
Tue, 10/23/18 - 09:24 am
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer

Seres Therapeutics, Inc. (Nasdaq:MCRB) announced on 10/22/18 the appointment of Kevin Horgan, M.D., as Executive Vice President and Chief Medical Officer. Dr. Horgan will lead Seres’ clinical... read more

Mon, 10/22/18 - 05:29 pm
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
  • Pamiparib is currently in Phase 3 trials globally and in China as a monotherapy
  • Of 23 patients with solid tumors, Ten had a best response of stable disease; four patients had a best... read more
Mon, 10/22/18 - 10:01 am
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
  • In the Tumor Treating Fields plus gemcitabine cohort, progression free survival and overall survival were each more than double those of the gemcitabine-treated historical control
  • ... read more
Mon, 10/22/18 - 09:47 am
Rebiotix to Report on Development of its Microbiome Health Index
  • The Index is a measurement meant to assess the extent of microbiome restoration following microbiota based therapy
  • Rebiotix is developing two microbiota based formulations to treat... read more
Mon, 10/22/18 - 09:31 am

Pages